Congratulations to the 2018 winners!
|Public Therapeutic Biotech||Private Therapeutic Biotech||Diagnostics and Beyond|
The Buzz of BIO contest provides an excellent opportunity for early-stage companies looking for companies hoping to make the connections needed to take their product to the next phase. Ten biotechs will be nominated in each of the three categories: Public Therapeutic Biotech, Private Therapeutic Biotech, and our newest category, Diagnostics and Beyond. The companies with the most number of votes in each category at the end of the voting period will win a complimentary conference registration and company presentation, along with exposure to thousands of industry elites and potential investors.
- In the Public Therapeutic Biotech category, nominated companies are actively developing a therapeutic product intended for FDA review that addresses human health issues and must be publicly traded.
- In the Private Therapeutic Biotech category, nominated companies are actively developing a therapeutic product intended for FDA review that addresses human health issues and must have raised at least $25MM by November 2017, but must not yet be publicly traded.
- In the Diagnostics and Beyond category, nominated companies are primarily focused in medical diagnostics, drug delivery, drug development tools, or digital health technologies.
Read the official contest rules here.